RecallDepth
Class II Ongoing

Nelarabine Injection, 250mg/50mL, (5mg/mL), packaged in: a) 50 mL Single-Dose Vial, NDC 70710-1839-1; b) 6 x 50 mL Single-Dose Vial, NDC 70710-1839-8, Rx only, Manufactured by Zydus Lifesciences Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc, Pennington, NJ

Company
Zydus Pharmaceuticals (Usa) Inc
Recall Initiated
February 13, 2025
Posted
March 12, 2025
Recall Number
D-0256-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,893 vials
Firm Location
Pennington, NJ, United States

Reason for Recall

Failed Impurities/Degradation Specifications

Distribution

USA Nationwide

Lot / Code Info

Lot: a) P300197, Exp. Aug-2025; P400113, Exp. May-26; b) P300169, Exp. Jun-2025; P400115, Exp. May-2026.

More recalls by Zydus Pharmaceuticals (Usa) Inc

View all recalls by this company →

Other recent Class II Drug recalls